YLC-20798-52672
3 vaccinations
1 coded response
27 check-ins
1 free-text entry
1 call case
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 196 / PA
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-21
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-12-17
Dose 3 — Pfizer-BioNTech
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-19
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-12-21
- 2021-12-23
- 2021-12-26
- 2021-12-31
-
2022-01-07
Survey response — day 21, dose 3MedDRA: Pre-eclampsia, Stillbirth — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Severe pre-eclampsia with urgent delivery and stillbirthMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — day 21, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-01-10
Call successfulDoes not wish to fill out VAERS report
- 2022-01-14
- 2022-01-21
- 2022-01-28
- 2022-12-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-07 | Successful 2022-01-10 |
Does not wish to fill out VAERS report |
Free text
Release 10 — day 21, dose 3
Symptoms: Severe pre-eclampsia with urgent delivery and stillbirth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Stillbirth | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release